Mgo One Seven LLC Biomarin Pharmaceutical Inc Transaction History

Mgo One Seven LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$84.2 - $98.62 $55,319 - $64,793	-657 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$80.14 - $106.07 $52,651 - $69,687	657 New	657 $55,000
Q3 2018 Oct 09, 2018	SELL	$93.92 - $105.72 $7,137 - $8,034	-76 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $621 - $741	8 Added 11.76%	76 $6,000
Q4 2017 Feb 16, 2018	BUY	$80.76 - $95.13 $5,491 - $6,468	68	68 $6,000

629

178M

1.98M

1.17M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.